CCI approves the acquisition of less than 5% shareholding in Intas Pharmaceuticals Limited by Canary Investments Limited and Link Investment Trust II
The Competition Commission of India (CCI) approves the acquisition of less than 5% shareholding in Intas Pharmaceuticals Limited by Canary Investments Limited …










